Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Spirometry Stories

2012-01-03 11:56:00

EXTON, Pa., Jan. 3, 2012 /PRNewswire/ -- Pharmaxis, Inc. today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific billing code, or J-code, for ARIDOL® (mannitol inhalation powder) Bronchial Challenge Test Kit. The unique, product-specific billing code, J7665 (mannitol, administered through an inhaler, 5 mg), became effective on January 1, 2012. (Photo: http://photos.prnewswire.com/prnh/20111107/NY00591 ) ARIDOL, the only dry powder...

2012-01-03 11:37:56

National Jewish Health researchers and their colleagues in the COPDGene research consortium report that a computerized form of radiology, known as quantitative CT, can offer valuable prognostic information for patients and doctors beyond the standard breathing tests most commonly used to evaluate chronic obstructive pulmonary disease (COPD). “Our findings indicate that quantitative CT scans can help identify patients at greater risk for damaging exacerbations of their disease,”...

2011-12-21 06:25:30

(Ivanhoe Newswire) — Adding inhaled powder mannitol to standard therapy for cystic fibrosis produced consistent lung function improvement for up to 52 weeks, according to this study. Mannitol treatment is not only efficient and safe, but it´s easy to administer as well. In the double-blind study, which was supported by Pharmaxis Limited, 318 patients were randomized to treatment with 400 mg bid inhaled mannitol or 50 mg bid inhaled mannitol (control group) for 26 weeks, followed...

2011-12-16 12:57:31

Adding inhaled dry powder mannitol to standard therapy for cystic fibrosis produced sustained improvement in lung function for up to 52 weeks, according to a new study. Along with the treatment's efficacy and good safety profile, the convenience and ease of administration of mannitol treatment may improve adherence with therapy in these patients. In the double-blind study, which was supported by Pharmaxis Limited, 318 patients were randomized to treatment with 400 mg bid inhaled mannitol...

2011-12-07 08:00:00

REDWOOD CITY, Calif., Dec. 7, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler (GP MDI; PT001) in patients with moderate-to-severe COPD. Four doses of GP MDI were compared to placebo and Atrovent® HFA Inhalation Aerosol, a short-acting muscarinic...

2011-11-29 07:03:00

TUSTIN, Calif., Nov. 29, 2011 /PRNewswire/ -- Uptake Medical® today announced the first commercial use of the InterVapor(TM) System for endoscopic lung volume reduction in a patient with severe emphysema. The patient successfully underwent treatment with InterVapor, the first endoscopic lung volume reduction system for the treatment of severe emphysema that uses the body's natural healing processes without leaving foreign materials in the lung. The patient was treated by the...

2011-11-16 07:27:53

Early screening of patients with chronic obstructive pulmonary disease (COPD) may help to detect lung cancer at an earlier stage, according to a new study. The research, published online today (16 November 2011) in the European Respiratory Journal, suggests that if COPD can be detected at an earlier stage, this will also aid the early detection of lung cancer. The news comes on World COPD Day, which aims to improve awareness of the condition and care of people with COPD around the...

2011-10-27 06:25:01

(Ivanhoe Newswire) -Do you experience shortness of breath while performing the most basic tasks such as doing light housework, taking a walk, or even washing and dressing? If you answered yes, then you might want to get checked for COPD. COPD or chronic obstructive pulmonary disease usually develops among men who were current or former heavy smokers. "Smoking is annually projected to cause more than 8 million deaths worldwide in the coming decades. Besides cardiovascular disease and...

2011-09-28 05:53:53

(Ivanhoe Newswire) -- A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease. The findings suggest that people with COPD and reduced lung function should be routinely screened for cardiovascular disease, as they appear to be at a considerably greater risk of it. The issue of co-morbidities, when an individual is affected by more than one condition at the same...

2011-09-27 13:45:59

The negative effects that premature birth can have on the lungs of babies could be as severe in moderately premature babies as those born extremely prematurely but may be reversed in their teenage years, according to a new study. The research will be presented at the European Respiratory Society Annual Congress in Amsterdam today (27 September 2011). Normal pregnancy lasts 40 weeks, which allows enough time for the infant to fully grow and develop before birth. Babies born prematurely...